{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:16:07Z","timestamp":1740122167983,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T00:00:00Z","timestamp":1474502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T00:00:00Z","timestamp":1474502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DK07634"],"award-info":[{"award-number":["T32DK07634"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008533","name":"Case Comprehensive Cancer Center, Case Western Reserve University","doi-asserted-by":"publisher","award":["5U54CA163060"],"award-info":[{"award-number":["5U54CA163060"]}],"id":[{"id":"10.13039\/100008533","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s10620-016-4315-y","type":"journal-article","created":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T05:13:23Z","timestamp":1474521203000},"page":"3169-3175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cleavage of E-Cadherin Contributes to Defective Barrier Function in Neosquamous Epithelium"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3000-7580","authenticated-orcid":false,"given":"Thomas M.","family":"Runge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zorka","family":"Djukic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Hallquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy C.","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,22]]},"reference":[{"key":"4315_CR1","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S0140-6736(09)60487-6","volume":"373","author":"NJ Shaheen","year":"2009","unstructured":"Shaheen NJ, Richter JE. Barrett\u2019s oesophagus. Lancet. 2009;373:850\u2013861.","journal-title":"Lancet"},{"key":"4315_CR2","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S0025-7125(02)00082-2","volume":"86","author":"SJ Spechler","year":"2002","unstructured":"Spechler SJ. Barrett\u2019s esophagus and esophageal adenocarcinoma: pathogenesis, diagnosis, and therapy. Med Clin N Am. 2002;86:1423\u20131445.","journal-title":"Med Clin N Am"},{"key":"4315_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1201\/b14015-9","volume-title":"Gastroesophageal Reflux Disease","author":"SJ Spechler","year":"2000","unstructured":"Spechler SJ. Barrett\u2019s esophagus. In: Orlando RC, ed. Gastroesophageal Reflux Disease. New York, NY: CRC Press; 2000:219\u2013258."},{"key":"4315_CR4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1053\/gast.2002.34748","volume":"123","author":"LB Gerson","year":"2002","unstructured":"Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett\u2019s esophagus in asymptomatic individuals. Gastroenterology. 2002;123:461\u2013467.","journal-title":"Gastroenterology"},{"key":"4315_CR5","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1053\/j.gastro.2003.09.030","volume":"125","author":"DK Rex","year":"2003","unstructured":"Rex DK, Cummings OW, Shaw M, et al. Screening for Barrett\u2019s esophagus in colonoscopy patients with and without heartburn. Gastroenterology. 2003;125:1670\u20131677.","journal-title":"Gastroenterology"},{"key":"4315_CR6","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1053\/j.gastro.2005.08.053","volume":"129","author":"J Ronkainen","year":"2005","unstructured":"Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett\u2019s esophagus in the general population: An endoscopic study. Gastroenterology. 2005;129:1825\u20131831.","journal-title":"Gastroenterology"},{"key":"4315_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1572-0241.2006.00379.x","volume":"101","author":"EM Ward","year":"2006","unstructured":"Ward EM, Wolfsen HC, Achem SR, et al. Barrett\u2019s esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms. Am J Gastroenterol. 2006;101:12\u201317.","journal-title":"Am J Gastroenterol"},{"key":"4315_CR8","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1001\/jama.287.15.1972","volume":"287","author":"N Shaheen","year":"2002","unstructured":"Shaheen N, Ransohoff DF. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: Scientific review. Jama. 2002;287:1972\u20131981.","journal-title":"Jama"},{"key":"4315_CR9","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","volume":"365","author":"F Hvid-Jensen","year":"2011","unstructured":"Hvid-Jensen F, Pedersen L, Drewes AM, et al. Incidence of adenocarcinoma among patients with Barrett\u2019s esophagus. N Engl J Med. 2011;365:1375\u20131383.","journal-title":"N Engl J Med"},{"key":"4315_CR10","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/jnci\/djr203","volume":"103","author":"S Bhat","year":"2011","unstructured":"Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression in Barrett\u2019s esophagus patients: results from a large population-based study. J Natl Cancer Inst. 2011;103:1049\u20131057.","journal-title":"J Natl Cancer Inst"},{"key":"4315_CR11","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1053\/j.gastro.2011.04.061","volume":"141","author":"NJ Shaheen","year":"2011","unstructured":"Shaheen NJ, Overholt BF, Sampliner RE, et al. Durability of radiofrequency ablation in Barrett\u2019s esophagus with dysplasia. Gastroenterology. 2011;141:460\u2013468.","journal-title":"Gastroenterology"},{"key":"4315_CR12","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1055\/s-0029-1243883","volume":"42","author":"W Lyday","year":"2010","unstructured":"Lyday W, Corbett F, Kuperman D, et al. Radiofrequency ablation of Barrett\u2019s esophagus: Outcomes of 429 patients from a multicenter community practice registry. Endoscopy. 2010;42:272\u2013278.","journal-title":"Endoscopy"},{"key":"4315_CR13","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/ajg.2009.88","volume":"104","author":"RE Pouw","year":"2009","unstructured":"Pouw RE, Gondrie JJ, Rygiel AM, et al. Properties of the neosquamous epithelium after radiofrequency ablation of Barrett\u2019s esophagus containing neoplasia. Am J Gastroenterol. 2009;104:1366\u20131373.","journal-title":"Am J Gastroenterol"},{"key":"4315_CR14","doi-asserted-by":"crossref","first-page":"AB116","DOI":"10.1016\/j.gie.2009.03.107","volume":"69","author":"LA Herrero","year":"2009","unstructured":"Herrero LA, Pouw RE, Van Vilsteren FG, et al. What are the outcomes of endoscopic radiofrequency ablation for very long segments of Barrett esophagus containing neoplasia? Gastrointest Endosc. 2009;69:AB116.","journal-title":"Gastrointest Endosc"},{"key":"4315_CR15","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa0808145","volume":"360","author":"NJ Shaheen","year":"2009","unstructured":"Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett\u2019s esophagus with dysplasia. N Engl J Med. 2009;360:2277\u20132288.","journal-title":"N Engl J Med"},{"key":"4315_CR16","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/ajg.2012.440","volume":"108","author":"B Jovov","year":"2013","unstructured":"Jovov B, Shaheen NJ, Orlando GS, et al. Defective barrier function in neosquamous epithelium. Am J Gastroenterol. 2013;108:386\u2013391.","journal-title":"Am J Gastroenterol"},{"key":"4315_CR17","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/j.cgh.2014.04.034","volume":"12","author":"S Pasricha","year":"2014","unstructured":"Pasricha S, Bulsiewicz WJ, Hathorn KE, et al. Durability and predictors of successful radiofrequency ablation for Barrett\u2019s esophagus. Clin Gastroenterol Hepatol. 2014;12:1840\u20131847.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4315_CR18","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1007\/s10620-011-1680-4","volume":"56","author":"BJ Vaccaro","year":"2011","unstructured":"Vaccaro BJ, Gonzalez S, Poneros JM, et al. Detection of intestinal metaplasia after successful eradication of Barrett\u2019s esophagus with radiofrequency ablation. Dig Dis Sci. 2011;56:1996\u20132000.","journal-title":"Dig Dis Sci"},{"key":"4315_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1053\/j.gastro.2013.03.008","volume":"145","author":"M Gupta","year":"2013","unstructured":"Gupta M, Iyer PG, Lutzke L, et al. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett\u2019s esophagus: Results from a US Multicenter Consortium. Gastroenterology. 2013;145:79\u201386.","journal-title":"Gastroenterology"},{"key":"4315_CR20","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/gut.2007.142539","volume":"57","author":"O Pech","year":"2008","unstructured":"Pech O, Behrens A, May A, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett\u2019s oesophagus. Gut. 2008;57:1200\u20131206.","journal-title":"Gut"},{"key":"4315_CR21","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1136\/gut.51.6.776","volume":"51","author":"K Basu","year":"2002","unstructured":"Basu K, Pick B, Bale R, et al. Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett\u2019s oesophagus: Factors determining persistence and recurrence of Barrett\u2019s epithelium. Gut. 2002;51:776\u2013780.","journal-title":"Gut"},{"key":"4315_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0016-5107(99)70219-1","volume":"50","author":"S Michopoulos","year":"1999","unstructured":"Michopoulos S, Tsibouris P, Bouzakis H, et al. Complete regression of Barrett\u2019s esophagus with heat probe thermocoagulation: Mid-term results. Gastrointest Endosc. 1999;50:165\u2013172.","journal-title":"Gastrointest Endosc"},{"key":"4315_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0016-5107(99)70230-0","volume":"50","author":"S Haag","year":"1999","unstructured":"Haag S, Nandurkar S, Talley NJ. Regression of Barrett\u2019s esophagus: the role of acid suppression, surgery, and ablative methods. Gastrointest Endosc. 1999;50:229\u2013240.","journal-title":"Gastrointest Endosc"},{"key":"4315_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1046\/j.1572-0241.2003.04018.x","volume":"99","author":"N Tobey","year":"2004","unstructured":"Tobey N, Hosseini S, Argote C, et al. Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am J Gastroenterol. 2004;99:13\u201322.","journal-title":"Am J Gastroenterol"},{"key":"4315_CR25","first-page":"421","volume-title":"The Esophagus","author":"R Orlando","year":"2004","unstructured":"Orlando R. Pathophysiolgoy of gastroesophageal reflux disease: Esophageal epithelial resistance. In: Castell DORJ, ed. The Esophagus. 4th ed. Philadelphia: Williams & Wilkins; 2004:421\u2013433.","edition":"4"},{"key":"4315_CR26","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1053\/gast.1996.v111.pm8898633","volume":"111","author":"NA Tobey","year":"1996","unstructured":"Tobey NA, Carson JL, Alkiek RA, et al. Dilated intercellular spaces: A morphological feature of acid reflux\u2013damaged human esophageal epithelium. Gastroenterology. 1996;111:1200\u20131205.","journal-title":"Gastroenterology"},{"key":"4315_CR27","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/ajg.2011.102","volume":"106","author":"B Jovov","year":"2011","unstructured":"Jovov B, Que J, Tobey NA, et al. Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease. Am J Gastroenterol. 2011;106:1039\u20131047.","journal-title":"Am J Gastroenterol"},{"key":"4315_CR28","first-page":"302","volume":"102","author":"J Alvaro-Villegas","year":"2010","unstructured":"Alvaro-Villegas J, Sobrino-Cossio S, Hernandez-Guerrero A, et al. Dilated intercellular spaces in subtypes of gastroesophagic reflux disease. Rev Esp Enferm Dig Organo Of Soc Esp Patol Dig. 2010;102:302\u2013307.","journal-title":"Rev Esp Enferm Dig Organo Of Soc Esp Patol Dig"},{"key":"4315_CR29","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1203\/01.PDR.0000125260.46861.32","volume":"55","author":"DE Moulton","year":"2004","unstructured":"Moulton DE, Crandall W, Lakhani R, et al. Expression of a novel cadherin in the mouse and human intestine. Pediatr Res. 2004;55:927\u2013934.","journal-title":"Pediatr Res"},{"key":"4315_CR30","doi-asserted-by":"publisher","first-page":"E101","DOI":"10.1038\/ncb0402-e101","volume":"4","author":"C Jamora","year":"2002","unstructured":"Jamora C, Fuchs E. Intercellular adhesion, signalling and the cytoskeleton. Nat Cell Biol. 2002;4:E101\u2013E108.","journal-title":"Nat Cell Biol"},{"key":"4315_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev.cellbio.13.1.119","volume":"13","author":"AS Yap","year":"1997","unstructured":"Yap AS, Brieher WM, Gumbiner BM. Molecular and functional analysis of cadherin-based adherens junctions. Annu Rev Cell Dev Biol. 1997;13:119\u2013146.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"4315_CR32","doi-asserted-by":"publisher","first-page":"C1174","DOI":"10.1152\/ajpcell.00015.2003","volume":"285","author":"X Guo","year":"2003","unstructured":"Guo X, Rao JN, Liu L, et al. Regulation of adherens junctions and epithelial paracellular permeability: A novel function for polyamines. Am J Physiol Cell Physiol. 2003;285:C1174\u2013C1187.","journal-title":"Am J Physiol Cell Physiol"},{"key":"4315_CR33","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.bbamem.2007.07.012","volume":"1778","author":"A Hartsock","year":"2008","unstructured":"Hartsock A, Nelson WJ. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta (BBA) Biomembr. 2008;1778:660\u2013669.","journal-title":"Biochim Biophys Acta (BBA) Biomembr"},{"key":"4315_CR34","doi-asserted-by":"publisher","first-page":"13308","DOI":"10.1074\/jbc.M114.559088","volume":"289","author":"C Herzog","year":"2014","unstructured":"Herzog C, Haun RS, Ludwig A, et al. ADAM10 is the major sheddase responsible for the release of membrane-associated meprin A. J Biol Chem. 2014;289:13308\u201313322.","journal-title":"J Biol Chem"},{"key":"4315_CR35","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.tibs.2005.05.006","volume":"30","author":"A-PJ Huovila","year":"2005","unstructured":"Huovila A-PJ, Turner AJ, Pelto-Huikko M, et al. Shedding light on ADAM metalloproteinases. Trends Biochem Sci. 2005;30:413\u2013422.","journal-title":"Trends Biochem Sci"},{"key":"4315_CR36","doi-asserted-by":"publisher","first-page":"9182","DOI":"10.1073\/pnas.0500918102","volume":"102","author":"T Maretzky","year":"2005","unstructured":"Maretzky T, Reiss K, Ludwig A, et al. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and \u03b2-catenin translocation. Proc Natl Acad Sci USA. 2005;102:9182\u20139187.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4315_CR37","first-page":"873","volume":"24","author":"RC Orlando","year":"2010","unstructured":"Orlando RC. The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms. Best Practice & Research Clinical. Gastroenterology. 2010;24:873\u2013882.","journal-title":"Gastroenterology"},{"key":"4315_CR38","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1055\/s-2002-35847","volume":"34","author":"M Kahaleh","year":"2002","unstructured":"Kahaleh M, Van Laethem J-L, Nagy N, et al. Long-term follow-up and factors predictive of recurrence in Barrett\u2019s esophagus treated by argon plasma coagulation and acid suppression. Endoscopy. 2002;34:950\u2013955.","journal-title":"Endoscopy"},{"key":"4315_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1046\/j.1442-2050.2003.00327.x","volume":"16","author":"R Yeh","year":"2003","unstructured":"Yeh R, Gerson L, Triadafilopoulos G. Efficacy of esomeprazole in controlling reflux symptoms, intraesophageal, and intragastric pH in patients with Barrett\u2019s esophagus*. Dis Esophagus. 2003;16:193\u2013198.","journal-title":"Dis Esophagus"},{"key":"4315_CR40","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1365-2036.2004.02127.x","volume":"20","author":"L Gerson","year":"2004","unstructured":"Gerson L, Boparai V, Ullah N, et al. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett\u2019s oesophagus treated with proton pump inhibitors. Aliment Pharmacol Ther. 2004;20:637\u2013643.","journal-title":"Aliment Pharmacol Ther"},{"key":"4315_CR41","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1111\/j.1572-0241.2006.00661.x","volume":"101","author":"SJ Spechler","year":"2006","unstructured":"Spechler SJ, Sharma P, Traxler B, et al. Gastric and esophageal pH in patients with Barrett\u2019s esophagus treated with three esomeprazole dosages: a randomized, double-blind, crossover trial. Am J Gastroenterol. 2006;101:1964\u20131971.","journal-title":"Am J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4315-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-016-4315-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4315-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T14:35:22Z","timestamp":1589726122000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-016-4315-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,22]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["4315"],"URL":"https:\/\/doi.org\/10.1007\/s10620-016-4315-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2016,9,22]]},"assertion":[{"value":"14 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Runge has no conflicts to declare. RC Orlando and Z Djukic have a patent for using the identification of fragments of e-cadherin for the diagnosis of GERD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}